![]() |
|
Connected As: <Anonymous> Contact: srcosmos@aegean.gr |
Article summary:
| Keywords | Antibiotics, Chemoprophylaxis, Cost, Surgery |
| Abstract | OBJECTIVE Surgical site infections (SSI) remain among the main causes of postoperative morbidity, prolonging hospitalization and increasing the cost of medical treatment in surgical units. In the present study the consumption of antibiotics was compared in a surgical department before and after the implementation of a pilot program, consisting of the administration of 1-3 doses of antibiotics to patients undergoing elective abdominal surgery. METHOD A pilot program was applied of the administration of antibiotic chemoprophylaxis to patients undergoing elective abdominal surgery. Administration of the first dose of antibiotic was made after the induction of anesthesia and up to two further doses of antibiotic were administered postoperatively. This regime was put into effect for a time period of two months (May and June 2002), after which the results were compared with the respective months of the previous year, before the program implementation (May and June 2001), in respect to the consumption and the cost of antibiotic treatment during patient's hospitalization. RESULTS Statistical analysis of the results showed a decrease of the hospitalization cost without increasing patient morbidity. In addition, the pilot program improved the effectiveness of the newer antibiotics restriction program, as their consumption was reduced by 53% and their acquisition cost by 47%.CONCLUSIONS Administration of chemoprophylaxis intraoperatively, with up to two doses postoperatively, can be safely applied in patients undergoing elective abdominal surgery, reducing the use of antibiotics and decreasing hospitalization cost, without affecting patient morbidity. |
| Full text | Full Text in PDF (147 KB) |
| Source link | http://www.mednet.gr/archives/2008-5/pdf/605.pdf |
| Included Refrences | 14 References (List...) |
| Cited by other Articles | 0 Citations (List...) |
| Name | Affiliation | Home page | Total pubs | |
| Alexiou K | Department of Surgery, "Sismanoglion" General Hospital, Athens, Greece | 2 | ||
| Antoniadou A | 4th Department of Internal Medicine, University of Athens, Athens, Greece | 1 | ||
| Antsaklis G | 1Department of Surgery, "Sismanoglion" General Hospital, Athens, Greece | 3 | ||
| Giamarellou H | 4th Department of Internal Medicine, University of Athens, Medical School, Athens, Greece | 4 | ||
| Giannitsioti E | 4th Department of Internal Medicine, University of Athens, Athens, Greece | 1 | ||
| Karanikas J | Department of Surgery, "Sismanoglion" General Hospital, Athens, Greece | 1 | ||
| Konstantinidou E | Department of Surgery, "Sismanoglion" General Hospital, Athens, Greece | elkonstantinidou@mailbox.gr | 2 |
References included in article:
| Order of appearence | Full citation | SRCosmos Link |
| 1 | Gruber UF, Elke R, Widmer M, Trippel M, Gerber H, 1983. Should antibiotic prevention be used in biliary tract surgery? Schweiz Med Wochenschr, 113:558–559 | |
| 2 | Lippert H, Gastinger J, 1998. Antimicrobial prophylaxis in laparoscopic and conventional cholecystectomy. Conclusions of a large prospective multicenter quality assurance study in germany. Chemotherapy, 44:355–356 | |
| 3 | Carey B, Cryan B, 2003. Antibiotic misuse in the community – a contributor to resistance? Ir Med J, 96:43–44, 46 | |
| 4 | Howard DH, 2004. Resistance-induced antibiotic substitution. Health Econ, 13:585–595 | |
| 5 | Furukawa K, Onda M, Suzuki H, Maruyama H, Akiya Y, Ashikari M, ET AL., 1999. The usefulness of conducting investigations on intraabdominal bacterial contamination in digestive tract operations. Surg Today, 29:701–706 | |
| 6 | Marshall D, Gough J, Grootendorst P, Buitendyk M, Jaszewski B, Simonyi S, ET AL., 2006. Impact of administrative restrictions on antibiotic use and expenditure in Ontario: Time series analysis. J Health Serv Res Policy, 11:13–20 | |
| 7 | Ozkurt Z, Erol S, Kadanali A, Ertek M, Ozden K, Tasyaran MA, 2005. Changes in antibiotic use, cost and consumption after an antibiotic restriction policy applied by infectious disease specialists. Jpn J Infect Dis, 58:338–343 | |
| 8 | Geroulanos S, Marathias K, Kriaras J, Kadas B, 2001. Cephalosporins in surgical prophylaxis. J Chemother, 1:23–26 | |
| 9 | Tin LY, Pitre M, Conly JM, 1995. Retrospective analysis of the clinical and economic outcomes of twice-daily dosing of cefotaxime in a Canadian tertiary care institution. Diagn Microbiol Infect Dis, 22:135–140 | |
| 10 | Smyth ET, Barr JG, O-Neill CA, Hogg GM, 1995. An assessment of the hidden and total antibiotic costs of four parenteral cephalosporins. Pharmacoeconomics, 8:541–550 | |
| 11 | Rotman N, 1990. Antibiotic prophylaxis in abdominal surgery. Chirurg, 116:401–403 | |
| 12 | Cuthbertson AM, Mc-Leish AR, Penfold JC, Ross H, 1991. A comparison between single and double dose intravenous Timentin for the prophylaxis of wound infection in elective colorectal surgery. Dis Colon Rectum, 34:151–155 | |
| 13 | Jones RN, 1991. Review of cefotaxime sodium for surgical prophylaxis. A model for the evolution toward single-dose or shortcourse cost-effective regimens. Diagn Microbiol Infect Dis, 14:190 | |
| 14 | Plosker GL, Foster RH, Benfield P, 1998. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections. Pharmacoeconomics, 13(1Pt 1):91–106 |